A Case of Multiple Antibiotic-Associated Hepatotoxicity in an Infant
https://doi.org/10.30895/2312-7821-2019-7-3-146-151
Abstract
Drug induced liver injury is one of the most frequent reasons for stopping treatment and the main cause of the onset and progression of acute liver failure, requiring liver transplantation. In children antibacterial drugs are on the first place in terms of hepatotoxicity, and the hepatocellular type is the most common type of liver damage. Often there is crosssensitivity within the same group of antibiotics, for example, beta-lactams. The aim: to analyze the causes of drug hepatotoxicity in the infant child while taking antibacterial agents. The article presents a clinical case of multiple hepatotoxicity caused by antibacterial agents such as beta-lactams, fluoroquinolones, sulfanilamides in one infant child, which suggests its genetic basis. It was shown that during therapy it is important to take into account the risk factors for hepatotoxicity (age, concomitant pathology, potential drug interactions with simultaneous use) and regularly evaluate the patient’s condition taking into account possible liver damage (including laboratory tests).
Keywords
About the Authors
S. S. PostnikovRussian Federation
Sergey S. Postnikov, Dr. Sci. (Med.), Professor
1 Ostrovityanova St., Moscow 117997, Russian Federation
117 Leninsky Ave., Moscow 119571, Russian Federation
N. V. Teplova
Russian Federation
Natalia V. Teplova, Dr. Sci. (Med.), Professor
1 Ostrovityanova St., Moscow 117997, Russian Federation
Scopus Author ID: https://www.scopus.com/authid/detail.uri?authorId=55199144000
V. V. Nikolaev
Russian Federation
Vasiliy V. Nikolaev, Dr. Sci. (Med.)
1 Ostrovityanova St., Moscow 117997, Russian Federation
117 Leninsky Ave., Moscow 119571, Russian Federation
F, K. Abdullaev
Russian Federation
Fuad K. Abdullaev
117 Leninsky Ave., Moscow 119571, Russian Federation
Scopus Author ID: https://www.scopus.com/authid/detail.uri?authorId=7006603725
Yu. N. Solontsov
Russian Federation
Yuriy N. Solontsov
117 Leninsky Ave., Moscow 119571, Russian Federation
A. E. Ermilin
Russian Federation
Alexey E. Ermilin
1 Ostrovityanova St., Moscow 117997, Russian Federation
117 Leninsky Ave., Moscow 119571, Russian Federation
M. N. Kostyleva
Russian Federation
Maria N. Kostyleva, Cand. Sci. (Med.)
1 Ostrovityanova St., Moscow 117997, Russian Federation
117 Leninsky Ave., Moscow 119571, Russian Federation
Anna N. Gracianskaya
Russian Federation
Anna N. Gratsianskaya, Cand. Sci. (Med.)
1 Ostrovityanova St., Moscow 117997, Russian Federation
References
1. Postnikov SS, Gratsianskaya AN, Kostyleva MN. Drug-induced liver injury. Pediatric practice. 2013;(6):9-15(in Russ.)
2. Serranti D, Montagnani C, Indolfi G, Chiappini E, Galli L, de Martino M. Antibiotic induced liver injury: what about children? J Chemother. 2013;25(5):255-72. https://doi.org/10.1179/1973947813Y.0000000090
3. Ferrajolo C, Verhamme KM, Trifirò G, 't Jong GW, Picelli G, Giaquinto C. Antibiotic-induced liver injury in paediatric outpatients: a case-control study in primary care databases. Drug Saf. 2017;40(4):305-15. https://doi.org/10.1007/s40264-016-0493-y
4. Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology. 2006;44(6):1581-8. https://doi.org/10.1002/hep.21424
5. Alyeva AA, Nikitin IG, Arkhipov AV. The treatment of acute chemotherapy-induced liver injury in women with breast cancer. Lechebnoe delo = The Journal of General Medicine. 2018;(2):74-84 (In Russ.)
6. Kukes VG, Volodin NN, Sychev DА, Koman IE. Features of the drugs use in children. Vestnik pediatricheskoy farmakologii i nutritsiologii = Bulletin of Pediatric Pharmacology and Nutrition. 2006;1(1):16–23 (In Russ.)
7. Amin MD, Harpavat S, Leung DH. Drug-induced liver injury in children. Curr Opin Pediatr. 2015;27(5):625-33. https://doi.org/10.1097/MOP.0000000000000264
8. Nikolaeva EА, Sukhorukov VS, Semyachkina АN, Vozdvizhenskaya ES, Tozliyan EV, Novikov PV. Effectiveness of drug correction of carnitine deficiency in children with genetically determined connective tissue diseases. Vestnik pediatricheskoy farmacologii i nutritsiologii = Bulletin of Pediatric Pharmacology and Nutrition. 2005;(3):16-20 (In Russ.)
9. Singh D, Cho WC, Upadhyay G. Drug-induced liver toxicity and prevention by herbal antioxidants: an overview. Front Physiol. 2016;6:363. https://doi.org/10.3389/fphys.2015.00363
10. Jackson MA, Schutze GE; Committee on Infectious Diseases. The use of systemic and topical fluoroquinolones. Pediatrics. 2016;138(5). https://doi.org/10.1542/peds.2016-2706
11. Yakovlev VP, Padejskaya EN, Yakovlev SV. Ciprofloxacin in clinical practice. Moscow: Vuzovskaya kniga; 2000 (In Russ.)
12. Vo HD, Xu J, Rabinowitz SS, Fisher SE, Schwarz SM. The liver in pediatric gastrointestinal disease. J Pediatr Gastroenterol Nutr. 2014;59(3):288-99. https://doi.org/10.1097/MPG.0000000000000444
13. Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22(4):411-8. https://doi.org/10.1111/j.1399-3038.2011.01169.x
Review
For citations:
Postnikov S.S., Teplova N.V., Nikolaev V.V., Abdullaev F.K., Solontsov Yu.N., Ermilin A.E., Kostyleva M.N., Gracianskaya A.N. A Case of Multiple Antibiotic-Associated Hepatotoxicity in an Infant. Safety and Risk of Pharmacotherapy. 2019;7(3):146-151. (In Russ.) https://doi.org/10.30895/2312-7821-2019-7-3-146-151